ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,847.85
0.09%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. XORTX Therapeutics Inc (XRTX)

  7. XORTX Therapeutics Inc (XRTX) News

XORTX Therapeutics (XRTX)

XORTX Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XRTX
DateTimeSourceHeadlineSymbolCompany
10/05/202421:10Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:XRTXXORTX Therapeutics Inc
30/04/202418:54GlobeNewswire Inc.XORTX Reprices Warrants Issued in Connection with Previous Private PlacementsNASDAQ:XRTXXORTX Therapeutics Inc
22/04/202412:00GlobeNewswire Inc.XORTX Announces Publication of Key Research in ADPKDNASDAQ:XRTXXORTX Therapeutics Inc
08/04/202412:30GlobeNewswire Inc.XORTX Welcomes New Member to the Board of DirectorsNASDAQ:XRTXXORTX Therapeutics Inc
08/04/202412:00GlobeNewswire Inc.XORTX Announces Participation in Spring 2024 Investor ConferencesNASDAQ:XRTXXORTX Therapeutics Inc
27/03/202409:00GlobeNewswire Inc.XORTX Announces New Clinical Advisory Board MemberNASDAQ:XRTXXORTX Therapeutics Inc
19/03/202409:00GlobeNewswire Inc.XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical TrialNASDAQ:XRTXXORTX Therapeutics Inc
11/03/202411:00GlobeNewswire Inc.XORTX Reprices Warrants Issued in Connection with Previous Private PlacementsNASDAQ:XRTXXORTX Therapeutics Inc
04/03/202412:00GlobeNewswire Inc.XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsNASDAQ:XRTXXORTX Therapeutics Inc
15/02/202412:00GlobeNewswire Inc.XORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsNASDAQ:XRTXXORTX Therapeutics Inc
02/02/202401:46GlobeNewswire Inc.XORTX Files an Amended and Restated Prospectus Supplement for the Offering of UnitsNASDAQ:XRTXXORTX Therapeutics Inc
15/01/202412:00GlobeNewswire Inc.XORTX Announces $2 Million Public OfferingNASDAQ:XRTXXORTX Therapeutics Inc
03/01/202412:25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
03/01/202412:00GlobeNewswire Inc.XORTX Submits a New Patent for the Treatment of Chronic Kidney DiseaseNASDAQ:XRTXXORTX Therapeutics Inc
02/01/202413:12Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
02/01/202412:00GlobeNewswire Inc.XORTX Welcomes New Member to the Board of DirectorsNASDAQ:XRTXXORTX Therapeutics Inc
30/11/202321:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
30/11/202312:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
30/11/202312:30GlobeNewswire Inc.XORTX Announces US ATM OfferingNASDAQ:XRTXXORTX Therapeutics Inc
30/11/202302:57Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XRTXXORTX Therapeutics Inc
29/11/202312:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
29/11/202312:00GlobeNewswire Inc.XORTX Meets Nasdaq Continued Listing RequirementsNASDAQ:XRTXXORTX Therapeutics Inc
13/11/202312:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
10/11/202312:00GlobeNewswire Inc.XORTX Clarifies Timing for Share ConsolidationNASDAQ:XRTXXORTX Therapeutics Inc
08/11/202322:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
08/11/202322:00GlobeNewswire Inc.XORTX Announces Share ConsolidationNASDAQ:XRTXXORTX Therapeutics Inc
02/11/202311:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
02/11/202311:00GlobeNewswire Inc.XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023NASDAQ:XRTXXORTX Therapeutics Inc
27/10/202322:30GlobeNewswire Inc.XORTX Announces Results of Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
25/10/202322:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:XRTX

Your Recent History

NASDAQ
AAZZUXX
Barclays Bank Plc Autoca...
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved